India caps trade margins on non-scheduled anti-cancer drugs at 30% of MRP
The Indian government has imposed a 30% cap on trade margins for non-scheduled anti-cancer medicines. This regulation applies to the difference between the price to stockists and the maximum retail price. The policy aims to make these essential drugs more affordable for patients. It will affect a wide range of anti-cancer medications not already under price control.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.



Discussion (0)
Log in to join the discussion and vote.
Log in